Karen Krasney

Karen Krasney discloses dealings in Capricor Therapeutics, Inc. to SEC (Form 4). The record holds 15 filings, for trades running from 21 January 2015 to 25 June 2026.

On the open market, the record shows 2 purchases worth €30k and 4 sales worth €1.3M. Netting one side against the other leaves €1.3M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 option exercises. Since January 2026: no purchases and 4 sales on the market.

Most recently, on 29 June 2026, the filings show an open-market sale worth €644k in Capricor Therapeutics, Inc. The most recent open-market purchase was published on 18 March 2016, 3,872 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.